Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B

This publication has 19 references indexed in Scilit:

• Survivin: A novel target for indomethacin-induced gastric injury
  Gastroenterology, 2005
• Aurora-A — A guardian of poles
  Nature Reviews Cancer, 2005
• Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF‐induced angiogenesis
  The FASEB Journal, 2004
• Molecular circuits of apoptosis regulation and cell division control: The survivin paradigm
  Journal of Cellular Biochemistry, 2004
• Aurora B Phosphorylates Centromeric MCAK and Regulates Its Localization and Microtubule Depolymerization Activity
  Current Biology, 2004
• Exploring the Functional Interactions between Aurora B, INCENP, and Survivin in Mitosis
  Molecular Biology of the Cell, 2003
• Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
  The Journal of cell biology, 2003
• Inhibition of Aurora B Kinase Blocks Chromosome Segregation, Overrides the Spindle Checkpoint, and Perturbs Microtubule Dynamics in Mitosis
  Current Biology, 2002
• Rebamipide, novel prostaglandin-inducer, accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer comparison with cimetidine
  Digestive Diseases and Sciences, 1995
• Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. Evidence for direct cellular action of prostaglandin.
  Journal of Clinical Investigation, 1988